KCT0000987招募中未知
A Single-center, Prospective, Randomized, Parallel group, Placebo-controlled Exploratory study on the effect of Renexin tablet in patients with recurrent vestibulopathy
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 70(Year)（—）
- 性别
- All
入选标准
- •Adults who complain repetitive vertigo and are diagnosed as recurrent vestibulopahty with VAS scrore between 4 and 8
排除标准
- •- patients with diagnosis of central type vertigo confirmed by MRI
- •- patients who recently diagnosed for peripheral vestibular disorders such as benign paroxysmal vertigo, Meniere's disease, migraine induced vertigo
- •- patients with bilateral vestibular function loss
- •- patients with acute vestibular neuritis occured within last 6 months
- •- patients with chronic liver disease, anemia
- •- pregnant or breast-feeding females
- •- patients with medication such as phenobarbital, phenytoin, carbamazepin, or ripampicin
- •- patients with medication of cilostazol or Ginko biloba at present
研究者
相似试验
暂停
不适用
This study is done to assess Effectiveness and Safety study of a three drug combination with a two drug combination for the treatment of type 2 diabetes mellitus in patients who have never received insulin.CTRI/2011/06/001841Abbott India Limited70
招募中
3 期
To Evaluate the Efficacy and Safety of Molnupiravir Capsule in Treatment of Subjects with Mild Corona virus Disease (COVID-19)CTRI/2021/05/033904Ms MSN Laboratories Private Limited
尚未招募
3 期
Efficacy and Safety of Fixed Dose Combination of Relugolix, Estradiol, and Norethindrone Acetate in Comparison to Leuprolide in Heavy Menstrual Bleeding Associated With Uterine FibroidsCTRI/2024/06/068615Sun Pharmaceutical Industries Limited (SPIL)
已完成
2 期
A clinical study to evaluate efficacy of a copper containing intrauterine device (Coated Copper- T) in reducing bleeding side effects.CTRI/2016/01/006535HLL Lifecare Limited176
招募中
2 期
A comparative clinical study to evaluate efficacy and safety of test drug in patients with Acute Ischemic strokeCTRI/2021/06/034395Reliance Life Sciences Pvt Ltd